BAK1 and endometrial cancer: One of such studies by Witek et al. (2016) examined gene expression profiles in endometrial cancer and revealed that BAK1 is overexpressed in grade 3 endometrial cancer which suggests that the tumor suppression system is still active and has yet to fulfil its role (Witek et al., 2016).